| 1.34 -0.02 (-1.47%) | 02-27 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.05 |
1-year : | 2.42 |
| Resists | First : | 1.75 |
Second : | 2.07 |
| Pivot price | 1.45 |
|||
| Supports | First : | 1.23 | Second : | 1.02 |
| MAs | MA(5) : | 1.37 |
MA(20) : | 1.44 |
| MA(100) : | 228.04 |
MA(250) : | 3993.53 |
|
| MACD | MACD : | -9.8 |
Signal : | -14.2 |
| %K %D | K(14,3) : | 25.4 |
D(3) : | 25.5 |
| RSI | RSI(14): 28.4 |
|||
| 52-week | High : | 10800 | Low : | 1.23 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ WOK ] has closed above bottom band by 25.8%. Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 93 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.4 - 1.41 | 1.41 - 1.42 |
| Low: | 1.33 - 1.34 | 1.34 - 1.35 |
| Close: | 1.34 - 1.36 | 1.36 - 1.37 |
WORK Medical Technology Group LTD, together with its subsidiaries, manufactures and sells medical consumables in the People's Republic of China and internationally. The company offers disposable medical devices, such as medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half mask; and visualized prostatic dilatation catheters. It also exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
Fri, 27 Feb 2026
WORK Medical Technology Group Shareholders Approve Sweeping Capital Restructuring - TipRanks
Tue, 10 Feb 2026
WORK Medical Technology Group Plans Major Capital Restructuring Ahead of February 25 AGM - TipRanks
Fri, 09 Jan 2026
Revenues Working Against WORK Medical Technology Group LTD's (NASDAQ:WOK) Share Price Following 100% Dive - simplywall.st
Mon, 29 Dec 2025
AI-powered blood test machine designed to support earlier disorder screening - Stock Titan
Wed, 24 Dec 2025
WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025 - Quiver Quantitative
Mon, 24 Nov 2025
WORK Medical Technology Group Enters Sales Agreement to Raise $200 Million - TipRanks
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 1 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0.1 (%) |
| Shares Short | 89 (K) |
| Shares Short P.Month | 55 (K) |
| EPS | -400 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 17.7 |
| Profit Margin | -10.9 % |
| Operating Margin | -17.6 % |
| Return on Assets (ttm) | -4.5 % |
| Return on Equity (ttm) | -6.5 % |
| Qtrly Rev. Growth | -14.4 % |
| Gross Profit (p.s.) | 1.91 |
| Sales Per Share | 8.07 |
| EBITDA (p.s.) | -1.29 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 6 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0.07 |
| Price to Sales | 0.17 |
| Price to Cash Flow | 0.26 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |